Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

The latest advances in pharmaceutical technology are leading to the development of cutting edged approaches to produce what is now known as the “Holy Grail” of medicine—nanopharmaceutics. Over the latest decade, the pharmaceutical industry has made important contributions to the scale up of these ne...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pharmaceutics
Päätekijät: Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2020
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7076491/
https://ncbi.nlm.nih.gov/pubmed/32053962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12020146
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia